Bank Of New York Mellon Corp Xencor Inc Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$24.79 - $30.86 $13.7 Million - $17 Million	550,870 New	550,870 $14.3 Million
Q3 2022 Nov 14, 2022	BUY	$24.62 - $32.44 $524,406 - $690,972	21,300 Added 3.98%	557,087 $14.5 Million
Q2 2022 Aug 15, 2022	SELL	$19.74 - $29.01 $809,122 - $1.19 Million	-40,989 Reduced 7.11%	535,787 $14.7 Million
Q1 2022 May 11, 2022	SELL	$26.68 - $41.63 $565,082 - $881,723	-21,180 Reduced 3.54%	576,776 $15.4 Million
Q4 2021 Feb 11, 2022	BUY	$33.67 - $43.44 $611,245 - $788,609	18,154 Added 3.13%	597,956 $24 Million
Q3 2021 Nov 12, 2021	BUY	$30.65 - $35.68 $103,995 - $121,062	3,393 Added 0.59%	579,802 $18.9 Million
Q2 2021 Aug 11, 2021	SELL	$34.33 - $44.68 $384,152 - $499,969	-11,190 Reduced 1.9%	576,409 $19.9 Million
Q1 2021 May 13, 2021	SELL	$40.81 - $53.88 $140,590 - $185,616	-3,445 Reduced 0.58%	587,599 $25.3 Million
Q4 2020 Feb 09, 2021	SELL	$36.63 - $47.63 $572,160 - $743,980	-15,620 Reduced 2.57%	591,044 $25.8 Million
Q3 2020 Nov 12, 2020	BUY	$30.09 - $43.02 $1.44 Million - $2.06 Million	47,859 Added 8.56%	606,664 $23.5 Million
Q2 2020 Aug 12, 2020	BUY	$27.76 - $33.42 $687,809 - $828,047	24,777 Added 4.64%	558,805 $18.1 Million
Q1 2020 May 06, 2020	SELL	$20.69 - $37.79 $261,687 - $477,967	-12,648 Reduced 2.31%	534,028 $16 Million
Q4 2019 Feb 14, 2020	BUY	$32.75 - $41.43 $117,507 - $148,650	3,588 Added 0.66%	546,676 $18.8 Million
Q3 2019 Nov 07, 2019	BUY	$33.73 - $46.27 $11.4 Million - $15.6 Million	337,015 Added 163.54%	543,088 $18.3 Million
Q2 2019 Aug 12, 2019	SELL	$29.6 - $40.93 $96,229 - $133,063	-3,251 Reduced 1.55%	206,073 $8.44 Million
Q1 2019 May 14, 2019	BUY	$27.85 - $38.09 $35,787 - $48,945	1,285 Added 0.62%	209,324 $6.5 Million
Q4 2018 Feb 11, 2019	SELL	$32.39 - $42.05 $446,075 - $579,112	-13,772 Reduced 6.21%	208,039 $7.52 Million
Q3 2018 Nov 09, 2018	SELL	$35.69 - $47.65 $800,205 - $1.07 Million	-22,421 Reduced 9.18%	221,811 $0
Q2 2018 Aug 06, 2018	BUY	$28.41 - $42.41 $1.87 Million - $2.79 Million	65,899 Added 36.95%	244,232 $9.04 Million
Q1 2018 May 15, 2018	BUY	$21.18 - $33.78 $103,782 - $165,522	4,900 Added 2.83%	178,333 $5.35 Million
Q4 2017 Feb 09, 2018	BUY	$19.29 - $24.83 $3.35 Million - $4.31 Million	173,433	173,433 $3.8 Million

Others Institutions Holding XNCR

# of Institutions

215

Shares Held

71.5M

Call Options Held

2.5K

Put Options Held

7.9K

Black Rock Inc. New York, NY

11.1M
Shares

$268 Million
0.0% of portfolio
Primecap Management CO Pasadena, CA

9.14M
Shares

$220 Million
0.14% of portfolio
Vanguard Group Inc Valley Forge, PA

7.6M
Shares

$183 Million
0.0% of portfolio
Eco R1 Capital, LLC San Francisco, CA

5.33M
Shares

$129 Million
4.65% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.93M
Shares

$94.8 Million
0.01% of portfolio

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.44B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account